- Anatomy Of The National Drug Code
- Will The FDA Delay The DSCSA?
- Pharma Serialization: Going Totally Global Soon
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- Will The DSCSA Cause Drug Shortages After January 1?
- Global Traceability Data Exchange: Troubled Waters Ahead
- Should You Off-Load Your DSCSA Obligations To Your Contract Partners?
Archive for the ‘Supply Network Blog’ Category
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
The first website I visit on Monday mornings is RxTrace
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
The knowledge presented in RxTrace, not simply the more common focus of the manufacturing, packaging, and regulatory requirements, but Dirk’s wholesale experience provides him with a complex view on the impacts to the end-to-end supply chain.
Look forward to RxTrace News-helps me to better manage key issues
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
RxTrace distills the complexities of pharmaceutical supply chain issues to simple concepts and also accurately projects issues on the horizon that industry leaders and legislators should heed.
RxTrace offers unique context and focus on our industry.
Easy to understand summary and discussion of complex current topics.
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
Top-selling 100 drugs to get cheaper soon - The Times of India lnkd.in/eHe5Sv6
Encouraging signs re drug quality from China. I hope they "get" it...India certainly doesn't shar.es/1X60LK
November 26, 2014 (11:02)
The DSCSA, the NDC, Inventory Management, GS1 GTINs...and TurkeysGreat news! Obama was looking for a legacy. HR 3204 can be it!
November 17, 2014 (3:30)
Will The DSCSA Cause Drug Shortages After January 1?Dirk, You have stated well the conundrum that Wholesaler Distributors face i...
November 1, 2014 (9:15)
The GS1 Healthcare US Guidance For DSCSA, Vsn 1.1The US law requires a verification based process when suspect product occurs....
Dirk A. Rodgers
October 31, 2014 (4:40)
The New Draft Guidance On The Effect of Section 585 of the FD&C Imposed By The DSCSARyan, It will be interesting to see if the FDA takes the view you propose. I...
October 31, 2014 (3:57)
The New Draft Guidance On The Effect of Section 585 of the FD&C Imposed By The DSCSAAgree on all parts there. I would agree that there is a requirement on temper...